Park and colleagues evaluated the CDH17 expression in more than 200 gastric carcinoma tissue samples, and reported that it was highly expressed in earlier TNM stages [20], Moreover, they found that reduced expression of CDH17 has been shown to be closely associated with tumor aggressiveness and lymph node metastasis of human gastric carcinoma [20]. Here, CDH17 is linked to neoplasm.